Mironid vs ONCOMATRYX
Mironid vs ONCOMATRYX, compared side by side on 21 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Mironid is on 59/100 and ONCOMATRYX on 50/100.
Where each one leads
Mironid
- our overall score: 59/100 against 50/100
ONCOMATRYX
- agent readiness: 36/100 against 21/100
- domain rating: 26/100 against 13/100
- headcount: 36 against 16
- funding raised: $107M against $46.0M
- LinkedIn following: 5,170 against 1,388
At a glance
| Measure | Mironid | ONCOMATRYX |
|---|---|---|
| What it is | Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD). | Developing Quantum ADCs against the tumor microenvironment for innovative cancer therapies. |
| Category | Biotechnology, Pharmaceuticals, Drug Discovery, Medical Devices | Biotechnology, Pharmaceuticals, Healthcare, Biotech |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2015 | 2009 |
| Headquarters | Glasgow, United Kingdom | Derio, Spain |
| Status | Active | Active |
Size, funding and growth
| Measure | Mironid | ONCOMATRYX |
|---|---|---|
| Employees | 16 | 36 |
| Total funding | $46.0M | $107M |
| Latest round | Series B | Funding Round |
| LinkedIn followers | 1,388 | 5,170 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Mironid | ONCOMATRYX |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 59/100 | 50/100 |
| Traction | 51/100 | 56/100 |
| Team | 70/100 | 30/100 |
| Search visibility | 20/100 | 37/100 |
| Quality | 68/100 | 55/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | F (36/100) |
| Domain ratingLink authority, 0-100 | 13/100 | 26/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Mironid | ONCOMATRYX |
|---|---|---|
| Hosting | Self Managed | Self Managed |
| CMS | WordPress | WordPress |
| Frameworks | Jquery, Tailwind CSS, Bootstrap | Jquery |
| Analytics | Not detected | Google Analytics 4 |
Mironid vs ONCOMATRYX: common questions
Which is better, Mironid or ONCOMATRYX?
On our 0-100 score Mironid rates higher (59/100 against 50/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 21 data points above: read the rows that match what you are buying for.
How do Mironid and ONCOMATRYX compare on the numbers?
Mironid leads on our overall score (59/100 against 50/100). ONCOMATRYX leads on agent readiness (36/100 against 21/100), domain rating (26/100 against 13/100), headcount (36 against 16), funding raised ($107M against $46.0M), LinkedIn following (5,170 against 1,388).
Read the full Mironid review and pricing or the ONCOMATRYX review and pricing. You can also browse other Mironid alternatives we track.